Stanislaw Adaszewski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stanislaw Adaszewski has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Agnes Meyder
Roche Pharmaceutical Research and Early Development, Operations Roche Innovation Center Basel Basel Switzerland
2 shared publications- Anna Vangone
Large Molecule Research Roche Pharmaceutical Research and Early Development Roche Innovation Center Munich Penzberg Germany
2 shared publications Chang-Yu Hsieh
Tencent Quantum Laboratory
2 shared publications- Jonathan Allcock
Tencent Quantum Laboratory
2 shared publications Martin Strahm
Roche Pharmaceutical Research and Early Development, Operations Roche Innovation Center Basel Basel Switzerland
2 shared publications- Shengyu Zhang
Tencent Quantum Laboratory, Tencent, Shenzhen, Guangdong 518057, China
2 shared publications
Latest Publications
- Open Access
- 21 November 2024
- Published by Elsevier in NeuroImage
- Vol. 304, 120934
Deep learning applied to the segmentation of rodent brain MRI data outperforms noisy ground truth on full-fledged brain atlases
- 21 November 2024
- Published by Elsevier in NeuroImage
- Vol. 304, 120934
Open AccessDeep learning applied to the segmentation of rodent brain MRI data outperforms noisy ground truth on full-fledged brain atlases
- Open Access
The prospects of Monte Carlo antibody loop modelling on a fault-tolerant quantum computer
Quantum computing for the biological sciences is an area of rapidly growing interest, but specific industrial applications remain elusive. Quantum Markov chain Monte Carlo has been proposed as a method for accelerating a broad class of computational problems, including problems of pharmaceutical interest. Here we investigate the prospects of quantum advantage via this approach, by applying it to the problem of modelling antibody structure, a crucial task in drug development. To minimize the resources required while maintaining pharmaceutical-level accuracy, we propose a specific encoding of molecular dihedral angles into registers of qubits and a method for implementing, in quantum superposition, a Markov chain Monte Carlo update step based on a classical all-atom force field. We give the first detailed analysis of the resources required to solve a problem of industrial size and relevance and find that, though the time and space requirements of using a quantum computer in this way are considerable, continued technological improvements could bring the required resources within reach in the future.
Open AccessThe prospects of Monte Carlo antibody loop modelling on a fault-tolerant quantum computer
Quantum computing for the biological sciences is an area of rapidly growing interest, but specific industrial applications remain elusive. Quantum Markov chain Monte Carlo has been proposed as a method for accelerating a broad class of computational problems, including problems of pharmaceutical interest. Here we investigate the prospects of quantum advantage via this approach, by applying it to the problem of modelling antibody structure, a crucial task in drug development. To minimize the resources required while maintaining pharmaceutical-level accuracy, we propose a specific encoding of molecular dihedral angles into registers of qubits and a method for implementing, in quantum superposition, a Markov chain Monte Carlo update step based on a classical all-atom force field. We give the first detailed analysis of the resources required to solve a problem of industrial size and relevance and find that, though the time and space requirements of using a quantum computer in this way are considerable, continued technological improvements could bring the required resources within reach in the future.
- Open Access
- 8 July 2022
- Published by Frontiers Media SA in Frontiers in Drug Discovery
- Vol. 2
The Prospects of Monte Carlo Antibody Loop Modelling on a Fault-Tolerant Quantum Computer
Quantum computing for the biological sciences is an area of rapidly growing interest, but specific industrial applications remain elusive. Quantum Markov chain Monte Carlo has been proposed as a method for accelerating a broad class of computational problems, including problems of pharmaceutical interest. Here we investigate the prospects of quantum advantage via this approach, by applying it to the problem of modelling antibody structure, a crucial task in drug development. To minimize the resources required while maintaining pharmaceutical-level accuracy, we propose a specific encoding of molecular dihedral angles into registers of qubits and a method for implementing, in quantum superposition, a Markov chain Monte Carlo update step based on a classical all-atom force field. We give the first detailed analysis of the resources required to solve a problem of industrial size and relevance and find that, though the time and space requirements of using a quantum computer in this way are considerable, continued technological improvements could bring the required resources within reach in the future.
- 8 July 2022
- Published by Frontiers Media SA in Frontiers in Drug Discovery
- Vol. 2
Open AccessThe Prospects of Monte Carlo Antibody Loop Modelling on a Fault-Tolerant Quantum Computer
Quantum computing for the biological sciences is an area of rapidly growing interest, but specific industrial applications remain elusive. Quantum Markov chain Monte Carlo has been proposed as a method for accelerating a broad class of computational problems, including problems of pharmaceutical interest. Here we investigate the prospects of quantum advantage via this approach, by applying it to the problem of modelling antibody structure, a crucial task in drug development. To minimize the resources required while maintaining pharmaceutical-level accuracy, we propose a specific encoding of molecular dihedral angles into registers of qubits and a method for implementing, in quantum superposition, a Markov chain Monte Carlo update step based on a classical all-atom force field. We give the first detailed analysis of the resources required to solve a problem of industrial size and relevance and find that, though the time and space requirements of using a quantum computer in this way are considerable, continued technological improvements could bring the required resources within reach in the future.
- Open Access
Automatic Pharma News Categorization
We use a text dataset consisting of 23 news categories relevant to pharma information science, in order to compare the fine-tuning performance of multiple transformer models in a classification task. Using a well-balanced dataset with multiple autoregressive and autocoding transformation models, we compare their fine-tuning performance. To validate the winning approach, we perform diagnostics of model behavior on mispredicted instances, including inspection of category-wise metrics, evaluation of prediction certainty and assessment of latent space representations. Lastly, we propose an ensemble model consisting of the top performing individual predictors and demonstrate that this approach offers a modest improvement in the F1 metric.
Open AccessAutomatic Pharma News Categorization
We use a text dataset consisting of 23 news categories relevant to pharma information science, in order to compare the fine-tuning performance of multiple transformer models in a classification task. Using a well-balanced dataset with multiple autoregressive and autocoding transformation models, we compare their fine-tuning performance. To validate the winning approach, we perform diagnostics of model behavior on mispredicted instances, including inspection of category-wise metrics, evaluation of prediction certainty and assessment of latent space representations. Lastly, we propose an ensemble model consisting of the top performing individual predictors and demonstrate that this approach offers a modest improvement in the F1 metric.